Apple Ordered to Appear in Australia and 3 Hot Stocks Moving Now
Radian Group Inc. (NYSE:RDN): Current price $7.00
Radian Group reported a fourth quarter revenue $226.1 million with a consensus of $200.03 million. Results include minimal net gains on investments and combined net gains from the change in fair value of derivatives and other financial instruments as well as an income tax provision of $20.5 million.
Apple Inc. (NASDAQ:AAPL): Current price $483.71
According to Reuters, Apple Inc. has been ordered to appear before Australia’s parliament with Microsoft (NASDAQ:MSFT) and Adobe Systems (NASDAQ:ADBE) to explain why local consumers pay so much for their products in spite of the strong Aussie dollar.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Charles Schwab Corp. (NYSE:SCHW): Current price $16.80
Acacia Research (NASDAQ:ACTG) announced that their Unified Messaging Solutions subsidiary has entered into a license and settlement agreement with Charles Schwab Corporation. This agreement resolves patent litigation that was pending in the United States District Court for the Northern District of Illinois.
Repros Therapeutics Inc. (NASDAQ:RPRX): Current price $10.95
Repros Therapeutics provided an update for both of their core clinical programs. As part of the Federal Drug Administration requirement for the total number of subjects to be exposed for six months, the company is conducting a 500 subject open label study. To date, the company has enrolled 499 subjects and expects the study to be fully enrolled this week. When the company receives guidance from the FDA, it will update the financial community. The company has requested an end of Phase 2 meeting for their vaginal Proellex program before the end of April.